Related Experiment Video
Updated: May 6, 2026
11:00
High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
Published on: November 28, 2016
11.9K
Establishment of a microfluidic and RPA-based platform for rapid multi-sample detection of Mycoplasma pneumoniae
Ling Zhang1, Cheng-Di Sun1, Jiao Luo1
1Department of Laboratory Medicine, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Diagnostic Microbiology and Infectious Disease
|April 14, 2025
Summary
This study introduces a new microfluidic assay using Recombinase Polymerase Amplification (RPA) for rapid and accurate detection of Mycoplasma pneumoniae. This simple, economical tool enhances laboratory diagnostics for this common respiratory pathogen.
Area of Science:
- Molecular diagnostics
- Microfluidics
- Pathogen detection
Background:
- Mycoplasma pneumoniae is a key cause of atypical pneumonia.
- Rapid and accurate pathogen detection is critical for patient management.
- Recombinase Polymerase Amplification (RPA) offers advantages over conventional PCR.
Purpose of the Study:
- To develop a novel detection platform for M. pneumoniae.
- To integrate microfluidic technology with RPA for enhanced diagnostics.
- To establish a simple, rapid, and accurate assay for M. pneumoniae.
Main Methods:
- Development of a microfluidic system integrated with RPA technology.
- Optimization of RPA for M. pneumoniae detection.
- Validation using quality controls and clinical samples.
Main Results:
- The RPA assay detected M. pneumoniae within 15-20 minutes.
- Sensitivity of the assay was determined to be 10 copies/μL.
- The microfluidic platform allowed simultaneous testing of multiple samples, including controls.
Conclusions:
- A microfluidic molecular assay system based on RPA was successfully established.
- The assay is simple, rapid, accurate, and economical.
- This provides a valuable new tool for laboratory detection of M. pneumoniae.
